Danish translation, linguistic validation, and cultural adaption of SCAR-Q

BackgroundScars can significantly impact an individual’s physical appearance, emotional well-being, and quality of life. Patient-reported outcome measures are essential for assessing these effects, with SCAR-Q being a validated tool that includes three independently functioning scales. This study aimed to translate, linguistically validate, and culturally adapt SCAR-Q for use in Denmark.MethodsSCAR-Q was translated into Danish using a six-step methodology based on the International Society for Pharmacoeconomics and Outcomes Research and the World Health Organization guidelines to ensure accuracy and cultural adaptation. The process included six steps: (1) preparation, (2) forward translations, (3) back translation, (4) expert panel review, (5) cognitive debriefing interviews with scar patients, and (6) final proofreading by experienced clinicians.ResultsThe forward translation resulted in a harmonized Danish version with minor discrepancies between the two translations that primarily involved terminology adjustments for words such as “contour,” “noticeable,” “flaky,” and “tingly.” The back translation confirmed conceptual equivalence, with only four minor refinements required. The expert panel deemed the translated version clinically and linguistically appropriate. Cognitive interviews with 10 patients demonstrated high comprehension, with no concerns identified. The final proofreading led to the final Danish SCAR-Q.ConclusionsThe Danish version of SCAR-Q was successfully translated, culturally adapted, and validated following a rigorous six-step process.Level of evidence: Not gradable.